Chemed Co. (NYSE:CHE) Stock Holdings Lifted by Waterloo Capital L.P.

Waterloo Capital L.P. lifted its position in Chemed Co. (NYSE:CHE) by 2.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,364 shares of the company’s stock after acquiring an additional 64 shares during the period. Waterloo Capital L.P.’s holdings in Chemed were worth $1,283,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in CHE. Norges Bank purchased a new position in shares of Chemed in the fourth quarter worth approximately $92,359,000. TD Asset Management Inc boosted its holdings in shares of Chemed by 164.3% during the fourth quarter. TD Asset Management Inc now owns 205,777 shares of the company’s stock worth $120,328,000 after purchasing an additional 127,934 shares during the period. Epoch Investment Partners Inc. boosted its holdings in shares of Chemed by 85.2% during the fourth quarter. Epoch Investment Partners Inc. now owns 152,162 shares of the company’s stock worth $88,977,000 after purchasing an additional 70,001 shares during the period. Impax Asset Management Group plc boosted its holdings in shares of Chemed by 19.5% during the second quarter. Impax Asset Management Group plc now owns 317,943 shares of the company’s stock worth $172,510,000 after purchasing an additional 51,974 shares during the period. Finally, ProShare Advisors LLC boosted its holdings in shares of Chemed by 6,288.9% during the first quarter. ProShare Advisors LLC now owns 50,600 shares of the company’s stock worth $32,482,000 after purchasing an additional 49,808 shares during the period. 95.85% of the stock is owned by hedge funds and other institutional investors.

Chemed Stock Performance

CHE stock opened at $577.59 on Thursday. The stock has a market cap of $8.74 billion, a P/E ratio of 31.09, a P/E/G ratio of 2.31 and a beta of 0.44. The firm has a 50 day simple moving average of $567.45 and a 200 day simple moving average of $578.35. Chemed Co. has a 52 week low of $497.36 and a 52 week high of $654.62.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12). The company had revenue of $595.88 million for the quarter, compared to analyst estimates of $599.20 million. Chemed had a return on equity of 29.21% and a net margin of 12.88%. The business’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $4.71 earnings per share. Sell-side analysts predict that Chemed Co. will post 21.77 EPS for the current year.

Chemed Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were issued a dividend of $0.50 per share. This is a boost from Chemed’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a dividend yield of 0.35%. The ex-dividend date was Monday, August 12th. Chemed’s dividend payout ratio (DPR) is currently 10.76%.

Insider Buying and Selling

In other Chemed news, EVP Nicholas Michael Westfall sold 2,000 shares of Chemed stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $561.58, for a total value of $1,123,160.00. Following the completion of the sale, the executive vice president now directly owns 5,990 shares in the company, valued at $3,363,864.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Chemed news, EVP Nicholas Michael Westfall sold 2,000 shares of Chemed stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $561.58, for a total value of $1,123,160.00. Following the completion of the sale, the executive vice president now directly owns 5,990 shares in the company, valued at $3,363,864.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director George J. Walsh III sold 200 shares of Chemed stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total transaction of $115,590.00. Following the completion of the sale, the director now owns 3,446 shares of the company’s stock, valued at $1,991,615.70. The disclosure for this sale can be found here. Over the last three months, insiders sold 6,744 shares of company stock worth $3,828,231. 3.32% of the stock is owned by company insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.